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Aim of this study was to investigate a pseudo-outbreak of Mycobacterium gordonae analyzing isolates detected 
from clinical and environmental samples. Mycobacterium gordonae was detected in 7 out of 497 broncho-alveolar 
lavage (BAL) samples after bronchoscopy procedure in patients admitted to a teaching hospital between January 
and April 2013. During this pseudo-outbreak clinical, epidemiological, environmental and molecular investigations 
were performed. None of the patients met the criteria for non-tuberculous mycobacterial (NTM) lung disease and 
were treated for M. gordonae lung disease. Environmental investigation revealed M. gordonae in 3 samples: in tap 
water and in the water supply channel of the washer disinfector. All the isolates were subjected to genotyping by 
pulsed-field gel electrophoresis (PFGE). The PFGE revealed that only patients’ isolates presented the same band 
pattern but no correlation with the environmental strain was detected. Surveillance of the outbreak and the strict 
adherence to the reprocessing procedure and its supplies resulted afterwards in no detection of M. gordonae in 
clinical respiratory samples. Clinical surveillance of patients was crucial to establish the start of NTM treatment. 
Regular screening of tap water and endoscopic equipment should be adopted to compare the clinical strains with 
the environmental ones when an outbreak occurs.
KEY WORDS: Broncoschopy, Mycobacterium gordonae, Pseudo-outbreak, Pulsed-field gel electrophoresis..
INTRODuCTION
Mycobacterium gordonae is a rare human 
pathogen despite its ubiquity in the environ-
ment (Weiss et al., 2012). The microorganism, 
previously known as the “tap water bacillus” or 
Mycobacterium aquae, was commonly isolat-
ed from water, soil and non-pasteurized fresh 
milk (Lessnau et al., 1993). Mycobacterium gor-
donae has a low virulence compared with oth-
ers non-tuberculous mycobacteria (NTM), with 
a mortality rate of less than 0.1% (Weiss et al., 
2012). Infection due to M. gordonae usually in-
volves children, immunocompromised patients 
(AIDS, steroid therapy, carcinoma, transplant 
recipient), or patients with underlying diseases. 
However. M. gordonae can also cause disease 
in immunocompetent patients and in surgical 
patients through respiratory, cutaneous, paren-
teral and gastrointestinal exposure (Gonzales et 
al., 1971; Aguado et al., 1987; Weinberger et al., 
1992; Bagarazzi et al., 1996; Bonnet et al., 1996; 
Harro et al., 1997; Rusconi et al., 1997; Phillips 
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et al., 2001; Foti et al.,2009; Mazumder et al., 
2010; Morimoto et al., 2015). Mycobacterium 
gordonae is the second most frequently identi-
fied species of NTM isolated in hospital labo-
ratories and pulmonary samples and about 1% 
of clinical specimens are culture positive for M. 
gordonae (Good et al., 1982; Tokars et al., 1990; 
Metchock et al.,1999; Hoefsloot et al., 2013). 
Moreover, M. gordonae can often contaminate 
the hospital water supply causing nosocomial 
outbreaks or pseudo-outbreaks. Pseudo-out-
breaks are defined as clusters of false infections 
or artefactual clusters of real infections (Wein-
stein et al., 1977). Several pseudo-outbreaks re-
lated to M. gordonae have been reported (Table 
3). Since 1984, in view of several reports con-
cerning the contamination of fiberoptic bron-
choscopy by Mycobacterium tuberculosis and 
NTM, it was recommended to disinfect bron-
choscopes and their accessories with both glu-
taraldehyde and iodophor solution to prevent 
contamination with mycobacteria (Davis et 
al.,1984). Bronchoscopes are used frequently, 
and their intricate design makes cleaning and 
disinfection difficult (Phillips et al., 2001). Ear-
ly identification of a pseudo-outbreak is man-
datory to avoid unnecessary antimycobacterial 
treatment and delay the true diagnosis. The au-
thors of this report tackled a pseudo-outbreak, 
most likely due to the contamination of bron-
choscope equipment.
MATERIALS AND METHODS
Clinical and microbiological detection
During the period between January and April 
2013, M. gordonae was isolated in 7 out of 497 
BAL from patients who underwent bronchos-
copy for various lung diseases including infec-
tions at the “Policlinico Umberto I” teaching 
hospital of Rome (Table 1). The criteria for 
classification and predisposing factors of NTM 
lung disease infection were in accordance with 
the standard criteria for the diagnosis of NTM 
infection (Griffith et al., 2007). Immunocom-
TABLE 1 - Characteristics of patients with bal positive for m. gordonae.
Pts Pulmonary 
disease
Symptmoms Comorbidity CT Imaging Presence 
AFB in 
BAL
TST reactive/
AFB + 
sputum
Therapy Outcome
1 Pulmonary 
fibrosis
Cough and 
dyspnoea
Right 
cardiopathy
Ground glass 
and bilateral 
pulmonary 
infection
Yes No/negative INH+RIF+PIR+
ETB stopped 
after 12 days
Dead*
2 COPD Worsening 
of cough
HCV + Fibrotic
small nodules,
bronchiect.
No Yes/negative INH+RIF Cured
3 COPD Worsening 
of cough
HCV+ bronchiect. No No/negative No Cured
4 Emp. Worsening 
of cough
None Bullous
cavity
No No/negative No Lung Tx
5 No Recent 
dyspnea
Uterine 
cancer
Suspicious 
lesion and 
mediastinal 
lymphnode 
involvement
No No/negative No NSCLC
6 No Recent 
dyspnea
None Irregular 
nodule
No No/negative No NSCLC
7 No Fever and 
dyspnea
None Pleural 
effusion
No No/negative No§ Cured
Pts (patients). CT (Computed Tomography). AFB (acid fast-bacilli). TST (Tuberculin skin test). INH (isoniazid). RIF (rifampin). PIR (pi-
razynamide). ETB (ethambutol). COPD (chronic obstructive pulmonary disease). LTBI (latent tuberculosis infection). HCV (Hepatitis C 
virus). Bronchiect. (bronchiectasis). Emp (emphysema). Tx (Transplant). NSCLC (non-small cell lung cancer). *Pt 1 died for pulmonary 
Aspergillosis (growth of Aspergillus spp from BAL, presence of galattomannan antigen from blood and BAL). §Pt 7 was cured with antibacte-
rial therapy.
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promising condition was defined as having 
human immunodeficiency virus infection, di-
abetes, active malignancy, or receiving chron-
ic immunosuppressive therapy. Demographic, 
clinical, radiological, microbiological and lab-
oratory data were prospectively recorded and 
each patient was monitored until the definite 
lung disease was reached and clinical outcome 
was observed. Expert clinicians decided wheth-
er to start antimicobacterial treatment based 
on the potential risk and benefit of therapy for 
each individual patient, according to clinical, 
radiological and microbiological features. Mi-
croscopic examination for detection of acid fast 
bacilli (AFB) was performed in all BALs sent to 
the laboratory for the diagnosis of M. tuberculo-
sis or other NTM infections. All clinical samples 
were digested-decontaminated using equal vol-
umes of 4% NaOH with 0.5% N-acetyl-L-cyste-
ine at room temperature. Mycobacteria growth 
indicator tube (MGIT) liquid medium vials 
(MGIT 960, Beckton Dickinson, Sparks, Mary-
land, USA) were inoculated after adding the re-
quired supplements according to the manufac-
turer’s instructions. Löwenstein-Jensen slants 
(Beckton Dickinson, Sparks, Maryland, USA) 
were also inoculated at the same time as the 
MGIT tubes. Other respiratory samples were 
collected after the detection of M. gordonae 
from BAL. The health management of the hos-
pital received the results of the clinical investi-
gation.
Environmental investigation
In July 2013 an environmental investigation 
was carried out on the bronchoscopy service 
involved in all seven cases of detection of M. 
gordonae in BAL. The centre has three bron-
choscopes to perform the service (about 20 
endoscopies per week) and it uses an Olympus 
autodisinfector to reprocess bronchoscopes 
(peracetic acid 0.1% at 35°C for 5 minutes, 
followed by rinsing with tap water, without a 
bacterial filter and drying through air flow). 
After reprocessing, bronchoscopes are stored 
in plastic bags ready for reuse. Fourteen envi-
ronmental samples were collected from water 
and surfaces of the endoscopy service (Table 
2) including: 3 biopsy/suction channels and 2 
connectors of the washer disinfector sampling 
by flushing of 50 ml of sterile saline (0.9%) and 
collecting in a sterile container (De Giusti et al., 
1993); 1 sample of tap water (100 ml) and 1 of 
the final rinse water of the washer disinfector 
(100 ml); 5 swabs from the internal surface 
of the autodisinfector, 1 swab from the water 
supply channel and 1 swab of the water sup-
ply channel of the washer disinfector. All sam-
ples were examined for mycobacterial growth 
by decontamination and inoculation into the 
MGIT tubes and Löwenstein-Jensen slants. All 
culture media were incubated at 36±1°C until 
mycobacterial growth was detected. Smears of 
colonies grown on the Löwenstein-Jensen me-
dium from clinical and environmental samples 
were stained with the Ziehl-Neelsen (Beckton 
Dickinson).
Molecular identification, typing and 
analysis
Mycobacteria were identified to the species 
level by conventional tests using the GenoType 
Mycobacterium CM assay according to the 
manufacturers’ procedures (Arnika, HainLife-
science GmbH, Nehren, Germany). The Gen-
oType protocol consists of PCR amplification, 
hybridization of the PCR products to the strip, 
detection and interpretation of the results.
Clonality of clinical and environmental isolates 
was determined by pulsed-field gel electropho-
resis (PFGE), using the CHEF Genomic DNA 
TABLE 2 - Enviromental samples positive  
for m. gordonae.
Type of sample Sample
No.
Positive
No. (%)
Flushing of biopsy/suction 
channel from Bronchoscopes
3 0 (a,b,c)
Flushing of connectors of the 
washer disinfector
2 0
Swabs of internal surfaces  
of the washer disinfector
5 0 (d,e,f)
Tap water 1 1 (7.14)
Swab from inside tap 1 1 (7.14)
Final rinse water of the washer 
disinfector
1 0
Swab of water supply channel  
of the washer disinfector
1 1 (7.14)
Total 14 3 (21.43)
Other species: Achromobacter xylosoxidans MDR (a). Klebsiella 
pneumoniae (b). Sphyngomonas paucimobilis (c). Micrococcus lu-
teus/lylae (d). Brevundimonas diminuta/vesicularis (e). Rhizobium 
radiobacter (f).
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Plug kit (Bio-Rad). Bacteria were inoculated 
in 20 ml of 7H9 medium (Beckton Dickinson), 
modified by the addition of 10% ADC (Beckton 
Dickinson), 0.1% Tween80 (wt/vol) (Sigma-Al-
drich) and 0.5 M sucrose (Sigma-Aldrich), and 
were incubated at 37°C for 14 days. 1 mg/ml 
D-cycloserine was added to the culture, which 
was incubated at 37°C for a further 16 hours 
and then centrifuged at 12000 rpm for 5 min-
utes. The pellet was resuspended in 150 µl of 
cell suspension buffer (Bio-Rad), incubated at 
75°C for 20 minutes with shaking (400 rmp), 
mixed with 150 µl of 2% low-melting-point 
agarose (Bio-Rad) at 55°C, and cast in plugs. 
Bacteria in plugs were lysed in 500 µl of ly-
sis buffer containing 2 mg/ml lysozyme (Bio-
Rad) for 4 hours at 37°C. The lysis buffer was 
then removed and plugs were incubated for 40 
hours at 50°C in 500 µl of proteinase K buffer 
and 20 µl of proteinase K (Bio-Rad). Plugs were 
washed twice for 30 minutes at 55°C with TE 
buffer (Tris 10 mM, EDTA 1 mM, pH 8.0) con-
taining 0.04 mg/ml of phenylmethylsulfonyl 
fluoride (PMSF) and 3 times for 30 minutes 
at room temperature with TE buffer. Genom-
ic DNA was digested overnight at 37°C with 
50U of restriction endonuclease XbaI in NE4 
buffer as recommended by the manufacturer 
(Euroclone). Digested plugs were loaded into 
a 1% agarose gel prepared in TBE 0.5X buffer. 
PFGE was run in TBE 0.5X containing 100 µM 
thiourea (Sigma-Aldrich), using a CHEF DRIII 
system (Bio-Rad) at 14°C, 6V/cm voltage gradi-
ent, initial switch time of 3 s, final switch time 
of 12 s, run time of 20 hours, included angle 
of 120°. The band patterns obtained were in-
terpreted as described by Tenover (Tenover et 
al., 1995). The analysis was performed using 
the InfoQuest FP (v5.1) software (Bio-Rad) and 
clustering was achieved using Dice coefficients 
and the unweighted pair group method with av-
erages (UPGMA).
Bibliographic search
In order to collect data on the M. gordonae pseu-
do-outbreak related to broncoschopy, we per-
formed a bibliographic search using both med-
ical databases PubMed (Medline) and Scopus 
with the key words: “Mycobacterium gordonae, 
pseudo-outbreak, broncoschopy, contaminated 
hospital equipment”, using the Boolean opera-
tor AND/OR. In addition to investigate non-in-
dexed articles, we investigated the “grey litera-
ture”, through Google.
RESuLTS
Clinical investigation
Clinical, radiological and microbiological char-
acteristics of patients with M. gordonae isolated 
from BAL are shown in Table 1. Seven patients 
had undergone bronchoscopy for the following 
reasons: pulmonary infection in pulmonary 
fibrosis (pt 1), worsening of Chronic Obstruc-
tive Pulmonary Disease (COPD) (pts 2 and 3), 
screening for lung transplant in severe emphy-
sema (pt 4), suspicion of pulmonary malignan-
cy (pts 5 and 6), onset of pleural effusion (pt 
7). According to the standard criteria of Amer-
ican thoracic Society (ATS) and Infectious Dis-
ease Society of America (IDSA) for diagnosis 
of NTM lung diseases infection (Griffith et al., 
2007), no patients had any signs or symptoms 
indicative of mycobacterial lung disease. No-
body made mention of productive sputum, fa-
tigue, malaise and chest pain to the clinician. 
No weight loss or hemoptysis were observed in 
the patients studied. Only one patient (pt 2) had 
radiological signs suspected most likely due to 
latent tuberculosis infection (LTI). The only pa-
tient who was smear-positive for AFB on direct 
examination of the BAL developed pulmonary 
infection due to the Aspergillus spp (pt 1). For 
all patients sputum examination for AFB and 
culture were negative for M. tuberculosis and 
NTM before and after bronchoscopy. No bacte-
rial growth was detected from the pleural fluid 
of the patient with fever and pleural effusion. 
After bronchoscopy, no patient referred onset 
of chest pain, worsening of cough, sputum pro-
duction, fever, shortness of breath. Concerning 
treatment adopted, only patient number 1 was 
treated with antituberculosis drugs (isoniazid, 
rifampin, pirazynamide and ethambutol) based 
on the observation of AFB in the BAL which 
were later identified as M. gordonae. The ther-
apy was stopped after 12 days due to clinical 
and radiological worsening of the patient and 
microbiological isolation of Aspergillus spp and 
Staphylococcus aureus from BAL. The patient 
died three days later after the exact diagnosis. 
Pseudo-outbreak of Mycobacterium gordonae in a teaching hospital 29
According to the Royal college of Physician 
guidelines for treatment of LTBI (2006), one 
patient (pt 2) received prophylaxis with isonia-
zid (INH) and rifampin (RIF) for three months. 
A pseudo-outbreak was suspected considering 
the discordance between the increasing num-
ber of M. gordonae cultures’ positive and the 
clinical finding of patients involved. The medi-
an time of positive culture detection was 9 days 
(range 5-13 days), immediately after the posi-
tive results environmental investigation was 
promptly started. 
No NTM infection was observed during the six 
months of follow-up to the population study.
Environmental investigation
Environmental investigation was carried out 
and qualitative analysis of the environmental 
samples revealed the presence of M. gordonae 
in 3 out of 14 samples (21.43%), in tap water, 
internal surface of the tap and into water sup-
ply channel of the washer disinfector (Table 
2). No M. gordonae was detected in the suction 
channel of the bronchoscope probably due to 
the presence of abundant multidrug-resistant 
microorganisms such as Achromobacter xy-
losoxidans, that may be able to mask and/or in-
hibit mycobacteria growth.
Molecular typing 
The PFGE analysis revealed that all M. gordonae 
strains isolated from patients’ BAL (M.GOR 1 
to M.GOR 7) showed an identical pulsotype, 
suggesting that the pseudo-outbreak was sus-
tained by a unique strain (Figure 1). It was pos-
sible to carry out the PFGE analysis of only one 
M. gordonae (M.GOR 8) isolated from environ-
mental samples (a swab from the water supply 
channel of the washer disinfector). This strain, 
compared with M. gordonae strains isolated 
from clinical samples, presented an unrelated 
pulsotype (Figure 1).
Bibliographic research 
As shown in Table 3, we included 16 articles 
from 1976 to 2015 in the review. To our knowl-
edge, during 2015 only two scientific articles 
were published regarding nosocomial pseu-
do-outbreaks due to M. gordonae associated 
with hospital water supply contamination (Pra-
baker et al., 2015; Zlojtro et al., 2015). Three 
studies (Leclerc et al., 1985; Stine et al., 1987; 
Gubler et al., 1992) dealt with broncoscopy 
procedures as a source of contamination for 
41 out of 511 (8.00%) known specimens. Only 
one Italian study dealt with M. gordonae pseu-
do-outbreaks while the others were from vari-
ous countries: in particular from USA (n. 7) and 
from France (n. 2).
DISCuSSION
Mycobacterium gordonae is the most common-
ly encountered NTM in water, with concentra-
tions as high as 1,000 colony-forming units per 
liter (Lessnau, 2015). Contamination of bron-
choscopes with or without infection of the pa-
tients has been reported for several pathogenic 
microorganisms, including M. tuberculosis and 
NTM (Gubler et al., 1992; Wallace et al., 1998). 
Literature data show that M. gordonae is less 
frequently involved in pseudo-outbreaks than 
other NTM (especially rapidly growing species) 
and, compared with other pathogenic species, it 
typically does not lead to infection (Phillips et al., 
2001). Positive cultures of sputum and BAL for 
M. gordonae should be interpreted with caution 
since these cultures are more likely to represent 
contamination (Mazumder et al., 2010; John-
son et al., 2014). However, if NTM are recovered 
from respiratory samples, it might be difficult 
FIGURE 1 - PFGE analysis of the strain of M. Gor-
donae. Dendrogram and PFGE patterns of XbaI-di-
gested chromosomal DNA of M. gordonae (M.GOR) 
strains. M.GOR 1 to 7: M. gordonae strains isolated 
from patients’ clinical samples (BAL). M.GOR 8: M. 
gordonae strain isolated from the environment. The 
dendrogram was constructed using Dice similarity 
coefficients (1.5% optimization and 1.5% position 
tolerance) and unweighted pair group method with 
averages.
L. Scorzolini, F. Mengoni, C.M. Mastroianni, R. Baldan, D.M. Cirillo, M. De Giusti, L. Marinelli, A. Cottarelli, L. Fattorini, V. Vullo30
to discriminate if they are pathogenic or not, 
even considering the possibility of NTM affect-
ing immunocompetent people, as described in 
the literature. On the other hand, the detection 
of NTM from sputum could delay the diagnosis 
of the other important lung diseases (Griffith et 
al., 2007). Therefore it is fundamental to care-
fully evaluate the patient’s clinical course and 
perform environmental investigation as soon as 
possible to determine the source. The diagnosis 
of NTM disease is complex and requires a mul-
tidisciplinary approach involving the clinician, 
microbiologist and radiologist. According to 
the criteria for NTM lung infection of Ameri-
can Thoracic Society clinical, radiological and 
microbiological evidence is required to achieve 
the definitive diagnosis. In addition, symptoms 
are not specific, most of the time the patient 
has a chronic cough due to underlying pulmo-
nary disease and systemic symptoms are fre-
quently not present. Radiological features are 
characteristic and finally microbiological evi-
dence plays a fundamental role. When possible, 
histological or cytological analysis help to es-
tablish the diagnosis in difficult cases (van In-
gen 2013). In the present study, all patients ob-
served showed signs and symptoms unrelated 
to mycobacterial disease and only one patient 
had suspected radiological features most likely 
due to LTI, with TST reactive. Nevertheless, one 
patient received treatment for active tuberculo-
sis. Concerning the clinical features of the other 
patients involved, the clinicians decided not to 
start antimycobacterial treatment according to 
the recommendation of ATS for NTM infection 
treatment. NTM lung disease is generally slowly 
progressive (relative to TB) so it allows enough 
time to collect multiple biological samples and 
microbiological data to be sure to reach the 
right diagnosis without embarking on long 
therapy with possible drug-related side-effects. 
In our experience, the detection of usually non 
pathogenic NTM as M. gordonae, the clinical 
presentation of patients and the same type of 
contaminated biological samples (BAL) made 
it possible to detect the pseudo-outbreak. The 
absence of M. gordonae in the following speci-
mens of patients confirmed that no patient was 
colonized by the same microorganism. Howev-
er the absence of AFB in the BAL and the long 
period needed for growth and identification of 
isolates, justified the delayed investigations and 
confirmed the high suspicion of contamina-
tion. According to recent reports by Diacon and 
Morimoto, a shorter time required to detect 
a positive culture and the subtype of M. gor-
donae could be used as the diagnostic criteria 
for M. gordonae pulmonary disease (Diacon et 
al., 2012; Morimoto et al., 2015). Prompt iden-
tification of the pseudo-outbreak and strict fol-
low-up of involved patients is fundamental to 
avoid delayed real diagnosis and unnecessary 
therapy. In our population study the source of 
contamination was most likely derived from the 
bronchoscopy but the original source could not 
be identified probably due to different M. gor-
donae pulsotypes present in the environmental 
water. Moreover the delayed identification of 
the pseudo-outbreak caused delay in the envi-
ronmental investigation. As widely described in 
the literature, NTM pseudo-outbreaks occurred 
in spite of several recommendations for disin-
fection of endoscopes (Kovaleva et al., 2013). 
Careful adherence to established decontamina-
tion guidelines is critical with endoscopy equip-
ment. Many outbreaks and pseudo-outbreaks 
due to NTM and other waterborne pathogens 
have been related to rinsing flexible endoscopy 
with non sterile water (Kovaleva et al., 2013). 
According to the Guideline Committee of the 
European Society of Gastrointestinal Endosco-
py, after the disinfection phase the final rinse 
should be carried out with sterile water or 
bacterium-free water (Beilenhoff et al., 2008). 
An environmental strategy to guarantee water 
quality for rinsing in automatic endoscope re-
processors should be the use of bacterial filters. 
Our experience shows that their absence on the 
water supply of the washer disinfector does not 
prevent contamination of waterborne patho-
gens (Table 2).
According to the guidelines of the World Health 
Organization, the European Commission direc-
tive (European Union Council Directive 98/83/
EC) states that drinking water should not con-
tain pathogenic microorganisms in a quantity 
or at a concentration able to adversely affect 
human health. However, the routine bacterio-
logical examinations carried out on drinking 
water do not include a search for NTM, and 
frequently the endoscopy service companies do 
not include any device that achieves water ste-
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rility. The ISO 15883-4:2008 (ISO 15883-4,2008) 
identified the responsibilities of the clinical ser-
vice provider who must ensure the water qual-
ity for the washer-disinfector. Furthermore the 
lack of drying procedure has been also associ-
ated with many outbreaks of endoscopy-related 
TABLE 3 - Pseudo-outbreak related to m. gordonae.
Micro. N° of
Specim.
Contaminated
Specim.
Source of
contamination
Cause of 
contamination
Clinical 
Implications
Reference
MG 7 Sputum Aerosol-
induction-
machine
Contaminated tap 
water
Not specified Gangadharam 
1976
MG 52 Bronchial 
secretion
Local 
anesthetic
Dye additive for local 
anesthetic
None Steere 1979
MG 32 Various Water Contaminated ice 
machines
Not specified Panwalker 
1986
MG 22 Bronchial 
secretion
Bronchoscope Tap water used to 
rinse instruments
2 pts treated for 
TBI
Stine 1987
MG 46 Various Culture 
medium
Antimicrobial solution 
in Bactec TB system
4 pts treated with 
anti-mycob. 
therapy
Tokars 1990
MG 3 Smears Water Contaminated 
deionized water unit
Not specified Gubler 1992
MCH/MG 14* Bronchial 
secretion
Bronchoscope Contaminated tank 
of bronchoscopy 
washing machine
4 pts treated for 
TBI
Gubler 1992
MG 84 Clinical 
specimen
Water Contaminated tap 
water used to mouth 
rinse before collection 
samples
None Arnow 2000
MG 5 Sputum/
gastric 
aspirate
Water Contaminated water 
from refrigerate 
fountain
4 pts treated for 
TBI
Lalande 2001
MG 16 Bronchial 
secretion
Bronchoscope Contaminated water 
of bronchoscopy 
washing machine
16 pts treated 
with 
anti-mycob. 
therapy
Rossetti 2002
MG ns Lung operative 
specimen
Water of 
surgical ward
Contamination of the 
apparatus for making 
super-oxidized water
None Fujita 2002
MG 15 Smears Water Ground water 
contamination of 
water tank
Not specified Moore 2005
MG 18 Various Not found Probable 
contaminated distilled 
water
None Esteban 2006
MG 27 Respiratory 
cultures
Water Contaminated ice 
machines
Not specified Azalea 2008
MG 35 Clinical 
specimen
Water Contaminated tap 
water
4 pts treated with 
anti-mycob. 
therapy
Prabaker 2015
MG 135 Pulmonary 
samples
Water Contaminated cold 
tap water
64 pts treated 
with 
anti-mycob. 
therapy
Zloitro 2015
Micro. (microorganism). Specim. (specimen). MG: M. gordonae. TBI: tuberculosis infection. Anti-mycob. (anti-mycobacterial).  
MCH: M. chelonae. Ns: not specified. *3 specimens were positive for MG. 
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infection due to NTM and other waterborne mi-
croorganisms (Beilenhoff et al., 2008), and the 
washer-disinfector performs only a short drying 
cycle by forced air. According to the American 
Guidelines (ASGE 2011), flushing with 70%-
90% ethyl or isopropyl alcohol is recommended 
for drying of endoscope channel to reduce the 
risk of remaining pathogens. Thus any gap be-
tween the disinfection phase and rinse/drying 
cycle should be evaluated carefully. In our expe-
rience also the low temperature at 35°C during 
reprocessing cycle fails in the effectiveness of 
high disinfection. 
The contamination of medical instruments is 
related to the high resistance of mycobacteria 
and especially of M. gordonae, which is able to 
survive after treatment with 2% glutaraldehyde 
for more than 10 minutes and to the practice 
of rinsing medical instruments with tap water 
after immersion in the disinfectant (Collins, 
1986; Stine et al., 1987). It has been reported 
that super-oxidized water is an effective disin-
fectant for Mycobacteria, however contamina-
tion of mycobacteria could have occurred in-
side the apparatus as well in the draining tubes 
(Ayliffe, 2000; Fujita et al., 2002). 
To our knowledge, as shown in Table 3, pseu-
do-outbreaks due to M. gordonae have been as-
sociated with the environmental contamination 
of several supplements of hospital tap water and 
different medical equipment (endoscopes, local 
anesthetic, aerosol machine, super-oxidized wa-
ter apparatus) by any step of use. As described 
in the literature, contamination with NTM can 
also occur after seemingly proper disinfec-
tion of the bronchoscopes has been performed 
(Davis et al., 1984). Even obtaining biological 
samples could result in contamination at any 
time from the collection of the specimen by the 
patient to the laboratory processing steps. It is 
generally accepted that the strategy to prevent 
infection due to endoscopy procedures should 
always include the molecular characterization 
of NTM and other pathogens. 
Our study had some limitations: we did not 
find the correlation between clinical and envi-
ronmental stains. This is probably due to the 
changing epidemiology of isolates from the wa-
ter system during the relatively long time be-
tween the execution of clinical specimens and 
the microbiological results. Moreover only one 
out of three of environmental strains of M. gor-
donae was genotyped due to sample contami-
nation. 
Diagnosis of NTM lung disease remains chal-
lenging due to aspecificity of symptoms, so 
clinical observation, radiologic tools and mi-
crobiology data still represent the gold standard 
for diagnosis. Our results confirms that clinical 
survey, together with environmental and molec-
ular investigations are valid tools to distinguish 
a pseudo-outbreak from true clinical infection. 
The adoption of this strategy could avoid un-
necessary antimicrobial treatment and allow 
an optimal public health intervention. 
Regularly screening for NTM of the hospital 
water and endoscopic instrumentation should 
be recommended to compare the clinical 
strains with the environmental ones, when the 
outbreak occurs.
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